Intuitive, secure, paperless.
Enhancing engagement and reactivity.
Real-time updates of enrollment metrics.
Patients select a trial, check their own eligibility, register and consent on the same platform.
The process is divided into sequential and intuitive steps, which enables researchers to interact with and follow up on the patient.
I perceive Allyfe as a great tool to outreach to many of my patients with a few clicks and give them the opportunity to participate in clinical trials, benefit from new treatments and become innovators on a unique platform that promotes equity and inclusion.
Professor Cedric Hermans
Head Division of Haematology
Cliniques universitaires Saint-Luc
UCLouvain, Belgium
As CRO, we know about the challenges clinical trial sponsors face. Our job is to find reliable and pragmatic solutions for our clients. We feel that our partnership with Allyfe helps us do that: the digital journey cuts administrative costs and saves time, and the motivation assessment will undoubtedly reduce dropouts.
Hadeel J.
Aesculape CRO
Allyfe is an excellent tool to manage multinational clinical trials in an efficient way. Its dedicated dashboards allow for real time monitoring of enrollment metrics across sites and countries.
Zoi Dorothea Pana, MD, MSc, PhD
EU COVID-19 Scientific Platform Member (European Commission)VACCELERATE WP10 lead
The Allyfe platform provides multiple benefits for clinical trial delivery. Key for its users is the ability to effectively bring together key metrics within a single dashboard for a trial. This feature alone results in huge productivity gains for its users.
John Jones
Oncacare Sr. Manager Site Network Development Western Europe
Our messaging app and videocall capabilities allow patients and researchers to communicate via instant messages, notifications and tele health meetings. Conversations are kept strictly confidential and stored exclusively on the platform. Sponsors can also communicate with research sites, monitor their performance and notify them of protocol admendements and the need for reconsent procedures.
Dashboards provide sponsors with real time updates on enrollment metrics and dropout risks. Sponsors can react instantly in case of lowering performance and communicate with research sites. Easy communication between patients and researchers motivate and engage patients, improving retention rates.
The researcher can actually visualize which step every patient is at on dedicated dashboards, how he responded to questionnaires, and which optional consent(s) the patient has selected, for instance. Clicking on a box reveals the detailed list of subjects, including filters and actions, which improves and expedites the enrollment process.